Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005062 · ClinicalTrials.gov registry record · Phase 3
Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission
A Phase 3 study, sponsored by Gustave Roussy, Cancer Campus, Grand Paris.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00005062: Completed Phase 3 study, sponsored by Gustave Roussy, Cancer Campus, Grand Paris.
NCT00005062 is a Phase 3 study that has completed, run by Gustave Roussy, Cancer Campus, Grand Paris. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005062, a Phase 3 study, has completed, sponsored by Gustave Roussy, Cancer Campus, Grand Paris.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells and prevent the spread of cancer to the brain. It is not yet known if standard-dose radiation therapy is more effective than high-dose radiation therapy in preventing the spread of limited-stage small cell lung cancer cells to the brain. PURPOSE: This randomized phase III trial is comparing two different regimens of radiation therapy to see how well they work in treating patients with limited-stage small cell lung cancer in complete remission.
Interventions
- RADIATION radiation therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-09 |
| Est. Completion | 2005-12 |
| Phase | Phase 3 |
What the finished NCT00005062 record still lists
NCT00005062 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which radiation therapy is the first listed.
NCT00005062 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00005062 about?
NCT00005062 is a clinical study titled "Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission". RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells and prevent the spread of cancer to the brain. It is not yet known if standard-dose radiation therapy is more effective than high-dose radiation therapy in preventing the spread of limited-stage small cell lung cancer cells to ...
What is the current status of trial NCT00005062?
This trial is currently completed. It is a Phase 3 study. The study started on 1999-09. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00005062?
The interventions under investigation include: radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00005062?
This trial is sponsored by Gustave Roussy, Cancer Campus, Grand Paris, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia